Medical Supply Stock Named 2021 Pick by J.P. Morgan

The firm raised its price target to $130 from $122

Deputy Editor
Dec 22, 2020 at 10:39 AM
facebook twitter linkedin


The shares of Medtronic PLC (NYSE:MDT) are up 0.3% at $114.74 at last check, after J.P. Morgan Securities made the stock a large-cap pick for 2021 and hiked its price target to $130 from $122. The firm cited the company's new CEO and operating model, and a strong product pipeline.

On the charts, MDT is still climbing steadily toward pre-pandemic levels, up around 59% since March. Today's earlier pullback to $114 was caught by the 10-day moving average. Year-to-date, the equity is just above its year-to-date breakeven mark. 

The majority of analysts are bullish on Medtronic stock, with 19 of the 21 in coverage at a "buy" or better rating. Furthermore, the 12-month consensus price target of $127.46 is an 11.4% premium to current levels. 

That said, now could be a good time to speculate on MDT's next move with options. The stock's Schaeffer's Volatility Index (SVI) of 26% stands higher than just 13% of all other readings in its annual range, implying that options players are pricing in relatively low volatility expectations at the moment. 

 

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners